Omar Khwaja - May 21, 2021 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role: Chief Medical Officer and Head of Research & Development.
Signature: /s/ Allison Dorval, as Attorney-in-Fact for Omar Khwaja
Stock symbol: VYGR
Transactions as of: May 21, 2021
Transactions value $: -$14,169
Form type: 4
Date filed: 5/25/2021, 04:31 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYGR	Common Stock	Sale	-$14.2K	-3.52K	-2.83%	$4.03	121K	May 21, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on May 20, 2021. The reporting person structured the durable automatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person.

Content

Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on May 20, 2021. The reporting person structured the durable automatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person.

Remarks:

Chief Medical Officer and Head of Research & Development.